FDA Inspection 1082630 — Nationwide Children's Hospital IRB
The FDA completed an inspection of Nationwide Children's Hospital IRB on March 11, 2019 in Columbus, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 11, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Columbus, OH (United States)
Additional Details
IRB